Central Nervous System Diseases  >>  AZD1466  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD1466 / AstraZeneca, Catalyst Biosci
ROBIN, NCT01039701 / 2009-015525-37: 4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease

Completed
2a
99
Europe
AZD1446, Placebo
AstraZeneca
Mild to Moderate Alzheimer's Disease
07/10
07/10
NCT01125683 / 2010-018273-38: To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease

Terminated
2
40
RoW
AZD1446, Donepezil, Placebo
AstraZeneca
Alzheimer´s Disease
03/11
03/11

Download Options